Analyst: Boston Scientific could take pacer lead

Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.

Boston Scientific, Leerink Swann, Medtronic, St. Jude Medical

News Well, Cardiac Rhythm Management, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BcqI8c